Greg Harrison
Stock Analyst at Scotiabank
(0)
# 4354
Out of 5,218 analysts
64
Total ratings
38.10%
Success rate
-9.24%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Keros Therapeutics | Maintains: Sector Outperform | 77 44 | 18.83 | 133.67% | 4 | Dec 13, 2024 | |
Agios Pharmaceutical... | Maintains: Sector Outperform | 53 75 | 39.09 | 91.86% | 4 | Dec 9, 2024 | |
BridgeBio Pharma | Maintains: Sector Outperform | 45 48 | 27.5 | 74.55% | 3 | Nov 25, 2024 | |
Apellis Pharmaceutic... | Maintains: Sector Perform | 35 30 | 33.24 | -9.75% | 2 | Nov 6, 2024 | |
Vertex Pharmaceutica... | Maintains: Sector Perform | 480 486 | 463.5 | 4.85% | 2 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Outperform | 62 70 | 64.78 | 8.06% | 2 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Outperform | 23 27 | 17.3 | 56.07% | 7 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Outperform | 305 310 | 245.25 | 26.4% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sector Outperform | 60 | 44 | 36.36% | 1 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sector Outperform | 18 | 7.47 | 140.96% | 1 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sector Perform | 24 | 27.91 | -14.01% | 3 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sector Outperform | 30 | 10.91 | 174.98% | 4 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sector Outperform | 6 | 3.86 | 55.44% | 1 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sector Outperform | 50 | 12.02 | 315.97% | 3 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sector Outperform | 22 | 8.67 | 153.75% | 1 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 13 15 | 1.44 | 941.67% | 3 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 303 280 | 361.37 | -22.52% | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 89 91 | 12.89 | 605.97% | 2 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 9 12 | 12.05 | -0.41% | 3 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 5 2 | 2.04 | -26.47% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 39 | 11.83 | 229.67% | 1 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 3 | 7.58 | -60.42% | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 70 | 5.57 | 1156.73% | 1 | Sep 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 20 | n/a | n/a | 2 | Sep 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 8 | 17.49 | -54.26% | 1 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | n/a | n/a | 1 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 25 7 | n/a | n/a | 4 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 67 54 | 24 | 125% | 1 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 18 6 | 1 | 500% | 2 | Mar 14, 2022 |